Is semaglutide intramuscular? The injection route explained

The biggest misconception: 'intramuscular' and 'injection' are not the same thing

Because semaglutide comes as a weekly injection, some people assume it works like a vaccine or an antibiotic shot, the kind that goes into the shoulder muscle. That assumption is wrong, and it is worth being direct about why.

Subcutaneous tissue is the thin layer of fat that sits between the skin and the muscle beneath it. Injecting into that layer produces a slow, steady release of semaglutide into the bloodstream, which is exactly what the medicine needs. If you want a fuller explanation of whether Wegovy is intramuscular or subcutaneous, that question gets its own dedicated page where the distinction is covered in detail. An intramuscular injection would deliver the drug faster and less predictably, and no clinical trial has evaluated semaglutide given that way. It has simply never been studied or approved for intramuscular use.

The pre-filled Wegovy pen removes most of the guesswork. You press it against clean skin at the chosen site, press the button, and a retractable needle reaches the correct subcutaneous depth automatically. The pen locks after use so the needle is never exposed. Our Wegovy overview page covers how the pen works in more detail, including the titration schedule prescribed by a clinician.

If you've already injected and you're unsure whether you reached the right layer, speak to your prescriber rather than waiting for your next scheduled dose.

Where on the body does the injection actually go?

Three sites are licensed for subcutaneous semaglutide injection: the belly (avoid the area within about 5 cm of the navel), the outer thigh, and the upper arm. Rotating between sites, and between spots within a site, reduces the chance of skin thickening or injection-site reactions, something people notice less when they vary where they inject each week.

Pinching a fold of skin before injecting is a technique some people find helpful, particularly if they have less subcutaneous fat at the chosen site. The patient information leaflet that comes with every Wegovy pen includes step-by-step illustrated guidance; read it before your first injection and keep it to hand. For a deeper look at how the molecule is structured and why the subcutaneous route suits it, our page on semaglutide's molecular weight explains the pharmacokinetics in plain terms.

One practical note: the upper arm can be awkward to self-inject. If you find it difficult to reach or to pinch the skin there, the thigh or abdomen is easier for most people administering their own doses.

What happens if the injection misses the subcutaneous layer?

An accidental intramuscular injection of semaglutide is unlikely to cause an immediate dramatic reaction, but it is not something to shrug off. Altered absorption could affect how quickly the medicine enters your system, and repeated incorrect injections into muscle can cause local tissue damage. Some people also find intramuscular injections more painful than subcutaneous ones, which is a useful clue that something may be off.

If you have any concern about where your injection landed (perhaps the pen didn't sit flush against the skin, or you felt more pain than usual) contact your prescriber the same day where possible. At our pharmacy, patients have access to aftercare seven days a week precisely for questions like this, not just for side effects. There is no question about injection technique that is too small to raise.

Beyond technique, it is worth knowing that semaglutide carries evidence for benefits that reach well beyond weight loss. The cardiovascular evidence behind semaglutide is one of the more striking parts of its clinical profile, and it underlines why getting the medicine into your system correctly matters.

A note on oral semaglutide and the 'no injection' alternative

If the injection itself is the thing putting you off, there is now a licensed alternative in the UK. As of June 2026, the MHRA approved Wegovy tablets (the first oral GLP-1 medicine licensed for weight management in the UK) making the question of intramuscular versus subcutaneous irrelevant for people who prefer tablets altogether. The tablet is taken once a day, first thing in the morning on an empty stomach, at least 30 minutes before food or drink.

The two forms contain the same active ingredient, semaglutide, but they are not interchangeable without clinical input; switching from the injection to the tablet, or vice versa, is a decision for a prescriber. If you'd like to compare the options or understand which might suit your circumstances, our treatment overview sets out what's currently available, and the cost context for private treatment is covered honestly on our Wegovy pricing page.

Semaglutide is a prescription-only medicine; a prescriber assesses clinical suitability before any treatment begins. Speak to our prescribers if you have questions about starting, switching or technique.